2026-11-13. The following slide deck was published by Viridian Therapeutics, Inc.
Detailed price information for Viridian Therapeutics Inc (VRDN-Q) from The Globe and Mail including charting and trades.
Detailed price information for Viridian Therapeutics Inc (VRDN-Q) from The Globe and Mail including charting and trades.
PHVS, UNCY, BHVN, CYTK, KURA, GRCE, INSM, RARE, CELC, RCKT_________________________________________________BUY | 12-month price target $31 (+51%) | Lumvoa...
Viridian Therapeutics' (VRDN) Lumvoa is off to a "stronger start" than anticipated, RBC Capital Mark
Viridian Therapeutics aims to leverage its infrastructure for both Lumvoa and elegrobart, potentially improving franchise economics. Read more on VRDN.
This is the newest page. Registered accounts read further back.